The Therapeutic Effects of Goreisan, a Traditional Japanese Herbal Medicine, on Lower-Limb Lymphedema after Lymphadenectomy in Gynecologic Malignancies: A Case Series Study

Table 1

Patient characteristics stratified by the CDT group and CDT-G group.

	Total (n = 19)	CDT group (n = 8)	CDT-G group (n = 11)	value
Age (mean, 95% CI)	56.4 (50.6–62.2)	55.3 (46.1–64.5)	57.3 (49.4–65.1)	0.737
Duration to diagnosis (median, range)	19.5 (4.2–243.1)	40.1 (4.4–243.1)	10.7 (4.2–162.1)	0.386
Body mass index (mean, 95% CI)	22.6 (20.6–24.6)	23.3 (20.2–26.5)	22.1 (19.4–24.8)	0.535
Type of cancer (n, (%))				0.965
Cervical cancer	10 (52.6)	4 (50.0)	6 (54.5)
Endometrial cancer	7 (36.8)	3 (37.5)	4 (36.4)
Ovarian cancer	2 (10.5)	1 (12.5)	1 (9.1)
Type of lymphadenectomy (n, (%))				0.830
PLN	16 (84.2)	7 (87.5)	9 (81.8)
PLN + PAN	3 (15.8)	1 (12.5)	2 (18.2)
Chemotherapy (n, (%))				0.425
Yes	15 (78.9)	7 (87.5)	8 (72.7)
No	4 (21.1)	1 (12.5)	3 (27.3)
Radiotherapy (n, %)				0.637
Yes	6 (31.6)	3 (37.5)	3 (27.3)
No	13 (68.4)	5 (62.5)	8 (72.7)
Affected side (n, (%))				0.255
Left	9 (47.4)	5 (62.5)	4 (36.4)
Right	10 (52.6)	3 (37.5)	7 (63.6)

CDT, complex decongestive therapy; CDT-G, combination of complex decongestive therapy and goreisan; CI, confidence interval; PLN, pelvic lymphadenectomy; PAN, paraaortic lymphadenectomy.